ES2056889T3 - Derivados de triazoldiacepina. - Google Patents

Derivados de triazoldiacepina.

Info

Publication number
ES2056889T3
ES2056889T3 ES88121165T ES88121165T ES2056889T3 ES 2056889 T3 ES2056889 T3 ES 2056889T3 ES 88121165 T ES88121165 T ES 88121165T ES 88121165 T ES88121165 T ES 88121165T ES 2056889 T3 ES2056889 T3 ES 2056889T3
Authority
ES
Spain
Prior art keywords
lower alkoxy
integer
carbon
lower alkyl
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88121165T
Other languages
English (en)
Spanish (es)
Inventor
Armin Walser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2056889T3 publication Critical patent/ES2056889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
ES88121165T 1987-12-18 1988-12-16 Derivados de triazoldiacepina. Expired - Lifetime ES2056889T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13472687A 1987-12-18 1987-12-18
US22794888A 1988-08-03 1988-08-03

Publications (1)

Publication Number Publication Date
ES2056889T3 true ES2056889T3 (es) 1994-10-16

Family

ID=26832617

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88121165T Expired - Lifetime ES2056889T3 (es) 1987-12-18 1988-12-16 Derivados de triazoldiacepina.

Country Status (21)

Country Link
EP (1) EP0320992B1 (zh)
JP (1) JPH0725762B2 (zh)
KR (1) KR890009932A (zh)
CN (1) CN1031057C (zh)
AT (1) ATE109148T1 (zh)
AU (1) AU612441B2 (zh)
CA (1) CA1327570C (zh)
CS (1) CS833288A2 (zh)
DE (1) DE3850866T2 (zh)
DK (1) DK704088A (zh)
ES (1) ES2056889T3 (zh)
FI (1) FI88799C (zh)
HU (1) HU204273B (zh)
IE (1) IE63762B1 (zh)
IL (1) IL88688A0 (zh)
MC (1) MC1999A1 (zh)
NO (1) NO167920C (zh)
NZ (1) NZ227341A (zh)
PT (1) PT89250B (zh)
RU (1) RU2094436C1 (zh)
YU (1) YU46991B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
JP2959598B2 (ja) * 1990-10-12 1999-10-06 吉富製薬株式会社 光学活性なチエノトリアゾロジアゼピン化合物
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
EP0661284A1 (en) * 1992-09-18 1995-07-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienodiazepine compound and medicinal use thereof
US5302590A (en) * 1992-12-18 1994-04-12 Hoffmann-La Roche Inc. Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
EP1925614A1 (en) * 2002-03-28 2008-05-28 Wisys Technology Foundation, Inc. Anxiolytic agents with reduced sedative and ataxic effects
DE60319812T2 (de) * 2002-03-28 2009-04-23 Wisys Technology Foundation, Inc., Madison Angstlösende wirkstoffe mit verminderten beruhigenden und ataktischen nebenwirkungen
AU2005260650A1 (en) 2004-06-30 2006-01-12 Wisys Technology Foundation, Inc. Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
CA2574220C (en) * 2004-07-27 2014-09-16 Gilead Sciences, Inc. Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
CA2579717A1 (en) * 2004-09-09 2006-03-23 Merck & Co., Inc. Tricyclic anilide spirolactam cgrp receptor antagonists
WO2006031676A2 (en) * 2004-09-13 2006-03-23 Merck & Co., Inc. Tricyclic anilide spirohydantoin cgrp receptor antagonists
WO2011161031A1 (en) * 2010-06-22 2011-12-29 Glaxosmithkline Llc Benzotriazolodiazepine compounds inhibitors of bromodomains
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
UA110640C2 (uk) 2011-05-05 2016-01-25 Янссен Фармацевтика Нв ПРОТИГРИБКОВІ 5,6-ДИГІДРО-4Н-ПІРОЛО[1,2-a][1,4]БЕНЗОДІАЗЕПІНИ ТА 6Н-ПІРОЛО[1,2-a][1,4]БЕНЗОДІАЗЕПІНИ, ЯКІ ЗАМІЩЕНІ ГЕТЕРОЦИКЛІЧНИМИ ПОХІДНИМИ
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
CN105492428A (zh) * 2013-05-01 2016-04-13 中央研究院 治疗β-地中海贫血和镰状细胞病的方法和组合物
CN103694253A (zh) * 2013-11-04 2014-04-02 湖南华腾制药有限公司 一种噻吩并三唑并[4,3-a][1,4]二氮杂卓类化合物的制备方法
EP3157928B1 (en) 2014-06-20 2019-02-13 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
EP3535253A1 (en) * 2016-11-01 2019-09-11 H. Hoffnabb-La Roche Ag 1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of cns related diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
ES2037013T3 (es) * 1986-01-21 1993-06-16 Boehringer Ingelheim Kg Procedimiento para preparar tieno-1,4-diazepinas.
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
US4960770A (en) * 1987-05-28 1990-10-02 Yoshitomi Pharmaceutical Industries, Ltd. 2-alkyl thieno(triazolo)diazepine compounds and pharmaceutical uses thereof

Also Published As

Publication number Publication date
FI885820A0 (fi) 1988-12-16
CS833288A2 (en) 1990-10-12
NO885597D0 (no) 1988-12-16
IE63762B1 (en) 1995-06-14
EP0320992A3 (en) 1991-01-09
KR890009932A (ko) 1989-08-05
EP0320992B1 (en) 1994-07-27
IL88688A0 (en) 1989-07-31
PT89250B (pt) 1993-07-30
ATE109148T1 (de) 1994-08-15
MC1999A1 (fr) 1990-01-26
AU2698988A (en) 1989-06-29
HUT50823A (en) 1990-03-28
CN1034722A (zh) 1989-08-16
CA1327570C (en) 1994-03-08
DE3850866D1 (de) 1994-09-01
NO885597L (no) 1989-06-19
JPH0725762B2 (ja) 1995-03-22
FI88799C (fi) 1993-07-12
NO167920C (no) 1991-12-27
DK704088D0 (da) 1988-12-16
EP0320992A2 (en) 1989-06-21
DK704088A (da) 1989-06-19
IE883758L (en) 1989-06-18
AU612441B2 (en) 1991-07-11
PT89250A (pt) 1989-12-29
FI88799B (fi) 1993-03-31
NZ227341A (en) 1992-01-29
YU46991B (sh) 1994-11-15
HU204273B (en) 1991-12-30
RU2094436C1 (ru) 1997-10-27
FI885820A (fi) 1989-06-19
JPH01197484A (ja) 1989-08-09
NO167920B (no) 1991-09-16
DE3850866T2 (de) 1994-12-08
CN1031057C (zh) 1996-02-21
YU228088A (en) 1990-06-30

Similar Documents

Publication Publication Date Title
ES2056889T3 (es) Derivados de triazoldiacepina.
FI820281L (fi) Foerfarande foer framstaellning av 2-penemkompositioner med forfarandet framstaellda nya 2-penemkompositioner och dessa inehaollande farmaceutiska blandningar
NO151364C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-substituerte heterocykliske forbindelser
ATE117295T1 (de) 4-oxochinolin-3-carbonsäure-derivate, ihre herstellung und ihre verwendung.
ES8507090A1 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
PT74199A (de) Neue trisubstituierte pyrimido<5,4-d>pyrimidine ihre herstel- lung und ihre verwendung als arzneimittel
DE69106902D1 (de) Imidazopyridazine, ihre Herstellung und Verwendung.
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
IE882107L (en) Pyrimidones
ATE58135T1 (de) 1,3-oxathianderivate.
ES8201541A1 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
TH6776EX (th) สารประกอบไตรไซคลิค
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
IT1207255B (it) Derivati 1,2,4-triazolici, un procedimento per la loro produzione, il loro uso come agenti antiriproduttivi e le composizioni farmaceutiche che li contengono.
ATE47389T1 (de) Kondensierte siebengliedrige heterozyklische verbindungen, ihre herstellung und verwendung.
TH6776A (th) สารประกอบไตรไซคลิค
HUT76276A (en) 3-substituted 1-arylindole compounds, pharmaceutical compositions containing them and their use
ATE19881T1 (de) Tropyl- und pseudotropylalkylbenzoate und ihre verwendung in der behandlung von migraene.
FI874107A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara piperidinderivat.
PT77572B (de) Neue semicarbazide ihre herstellung und verwendung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 320992

Country of ref document: ES